Enter at least 3 characters
HOME > About us



We are an international company, with our headquarter based in Parma, Italy. With 80 years of experience and a strong focus on research, development, production and the commercialisation of innovative medicines in the Respiratory, Neonatology, Rare Disease and Special Care Therapeutic Areas.

With a turnover of more than €1.4 billion sales for the Chiesi Group we are among the top 50 pharmaceutical companies in the world. Our production sites are in Parma, Italy, Blois (France) and Santana De Parnaiba (Brazil).


Our R&D centres in Parma (Italy), Paris (France), Cary (USA), Chippenham (UK) and the R&D team from the newly-acquired Danish company Zymenex, integrate our efforts to advance Chiesi's pre-clinical, clinical and registration programmes.

We export to more than 70 countries with a direct presence in 26. The Chiesi Group employs approximately 4,500 people, 560 of whom are dedicated to R&D activities and 720 of whom work at production sites in Italy, France and Brazil.


Mission and values

Our aim is to be recognised as a research-focused international Group, able to develop and commercialise innovative pharmaceutical solutions to improve the quality of human life.

We wish to maintain a high quality entrepreneurial team characterised by self-confidence and a collaborative spirit.

Our goal is to combine commitment to results with integrity, operating in a socially and environmentally responsible manner.


Please find out more about our mission and values here.


Social responsibility

Chiesi strongly believes in people and that every company should focus on the individual. A company's decisions and activities have a direct impact on people: patients, company staff and family, suppliers, customers, the local community, banks, government, media, competitors and all other interested parties.

Corporate Social Responsibility in Chiesi’s way of thinking means a good relationship with the community and our employees, the environment and our surroundings.


The Chiesi Foundation

The Chiesi Foundation was founded in 2005 as a nonprofit organization that aims to promote health and to ease the suffering of patients through research, knowledge exchange and training of health professionals. The emphasis is in the fields of respiratory, rare and neonatal diseases.


Chiesi in brief:

  • Four international research centres
  • Three production facilities
  • 1,300 active patents
  • 42 ongoing projects in various phases of clinical development
  • Our medicines are available in more than 89 countries